WP Advisors’s Vertex Pharmaceuticals VRTX Stock Holding History

WP Advisors’s Portfolio VRTX Stock Details VRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.46M	Hold	2,945	–	–	0.35%	46
2026 Q1	$1.32M	Sell	2,945 -73	-2%	-$34K	0.34%	43
2025 Q4	$1.37M	Sell	3,018 -190	-6%	-$81.9K	0.34%	43
2025 Q3	$1.26M	Hold	3,208	–	–	0.32%	42
2025 Q2	$1.43M	Buy	3,208 +9	+0.3%	+$4.15K	0.39%	41
2025 Q1	$1.55M	Hold	3,199	–	–	0.52%	36
2024 Q4	$1.29M	Hold	3,199	–	–	0.43%	43
2024 Q3	$1.49M	Sell	3,199 -845	-21%	-$406K	0.54%	40
2024 Q2	$1.9M	Sell	4,044 -100	-2%	-$43.4K	0.61%	36
2024 Q1	$1.73M	Sell	4,144 -70	-2%	-$29.6K	0.57%	38
2023 Q4	$1.71M	Sell	4,214 -337	-7%	-$124K	0.63%	34
2023 Q3	$1.58M	Sell	4,551 -34	-0.7%	-$11.9K	0.65%	35
2023 Q2	$1.61M	Sell	4,585 -417	-8%	-$141K	0.65%	34
2023 Q1	$1.58M	Hold	5,002	–	–	0.65%	37
2022 Q4	$1.44M	Sell	5,002 -705	-12%	-$215K	0.65%	36
2022 Q3	$1.65M	Buy	5,707 +18	+0.3%	+$5.18K	0.75%	32
2022 Q2	$1.6M	Hold	5,689	–	–	0.7%	32
2022 Q1	$1.49M	Sell	5,689 -50	-0.9%	-$11.9K	0.61%	37
2021 Q4	$1.26M	Sell	5,739 -738	-11%	-$144K	0.52%	44
2021 Q3	$1.18M	Buy	6,477 +3,002	+86%	+$586K	0.48%	44
2021 Q2	$701K	Buy	3,475 +252	+8%	+$52.7K	0.29%	55
2021 Q1	$693K	Buy	3,223 +1,333	+71%	+$293K	0.3%	49
2020 Q4	$447K	Buy	+1,890	New	+$434K	0.22%	64
2018 Q3	–	Sell	-50	Closed	-$8K	–	283
2018 Q2	$8K	Buy	+50	New	+$7.75K	0.01%	234

Other funds holding VRTX

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

WP Advisors's VRTX Position: Q2 2026 in Review

WP Advisors held its Vertex Pharmaceuticals (VRTX) position steady in Q2 2026 at 2,945 shares worth $1.46M. The position accounts for 0.35% of the portfolio, ranked #46.

WP Advisors first reported a position in VRTX in Q2 2018 and has held it in 24 quarters since. The position peaked at $1.9M in Q2 2024. 1,757 funds tracked by Wall St. Rank hold VRTX as of Q2 2026.

WP Advisors held 2,945 shares of Vertex Pharmaceuticals worth $1.46M as of Q2 2026.
WP Advisors left its Vertex Pharmaceuticals share count unchanged in Q2 2026.
Vertex Pharmaceuticals made up 0.35% of WP Advisors's portfolio in Q2 2026, its #46 holding.
WP Advisors first reported a position in Vertex Pharmaceuticals in Q2 2018 and has held it in 24 quarters since.
WP Advisors's Vertex Pharmaceuticals position peaked at $1.9M in Q2 2024.
1,757 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q2 2026.

Based on WP Advisors's 13F filing for Q2 2026, filed 29 Jul 2026.